FDA Adverse Event Injury Summary report: N

MOSAIC AORTIC BIOPROSTHETIC HEART VALVE

MDR report key: 8124617 · Received December 3, 2018

Report

Report Number
2025587-2018-03270
Event Type
Injury
Date Received
December 3, 2018
Date of Event
October 19, 2018
Report Date
December 3, 2018
Manufacturer
MEDTRONIC HEART VALVE DIVISION
Product Code
LWR
PMA / PMN Number
P990064
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
GA, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

CORRECTION TO ADD PMA / 510(K) # TO FIELD. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Additional Manufacturer Narrative · 1

CONCLUSION: WITHOUT THE RETURN OF THE PRODUCT, NO DEFINITIVE CONCLUSION CAN BE MADE REGARDING THE CLINICAL OBSERVATION. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Description of Event or Problem · 1

MEDTRONIC RECEIVED INFORMATION THAT SIX YEARS AND TEN MONTHS POST IMPLANT OF THIS BIOPROSTHETIC AORTIC VALVE, A TRANSCATHETER VALVE WAS IMPLANTED VALVE-IN-VALVE. THE INDICATIONS FOR VALVE REPLACEMENT WERE STENOSIS AND INSUFFICIENCY. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
964119 MOSAIC AORTIC BIOPROSTHETIC HEART VALVE HEART-VALVE, NON-ALLOGRAFT TISSUE LWR MEDTRONIC HEART VALVE DIVISION 305U227

Patients

Seq Age Sex Outcome Treatment
1 72 YR Required Intervention